Drug development advances in human genetics‐based targets
Abstract Drug development is a long and costly process, with a high degree of uncertainty from the identification of a drug target to its market launch. Targeted drugs supported by human genetic evidence are expected to enter phase II/III clinical trials or be approved for marketing more quickly, sp...
Main Authors: | Xiaoxia Zhang, Wenjun Yu, Yan Li, Aiping Wang, Haiqiang Cao, Yuanlei Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-02-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.481 |
Similar Items
-
Genetic variants associated with the occurrence and progression of adolescent idiopathic scoliosis: a systematic review protocol
by: Elizabeth A. Terhune, et al.
Published: (2022-06-01) -
Genomic and neuroimaging approaches to bipolar disorder
by: Mojtaba Oraki Kohshour, et al.
Published: (2022-03-01) -
Progress in Genetic Studies of Tourette’s Syndrome
by: Yanjie Qi, et al.
Published: (2017-10-01) -
Genetic-molecular characterization in the diagnosis of primary immunodeficiencies
by: Gesmar Rodrigues Silva Segundo
Published: (2021-03-01) -
Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN)
by: Claire E. Fishman, et al.
Published: (2019-11-01)